Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEZ235 (RTB101) for Prevention of Respiratory Tract Infections in Elderly
NCT03373903Phase 2Active, not recruiting
- Sponsor
- resTORbio
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dactolisib in respiratory tract infection (RTI), sponsored by resTORbio. Started Nov 2017; status: active, not recruiting.
02
Drugs
dactolisib
03
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT03373903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373903.